Estás usando un navegador no soportado
Usar Internet Explorer está desaconsejado por problemas de seguridad. Para ver correctamente esta web, por favor use cualquier navegador moderno: Chrome, Firefox, Edge, Safari u otro de su elección.
En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias
FILTRAR POR:
1454 ARTÍCULOS , VIENDO DEL 16 AL 30
Current view from Alzheimer disease to type 2 diabetes mellitus
Rasool M, Malik A, Qazi AM, Sheikh IA, Manan A, Shaheen S, Qazi MH, Chaudhary AG, Abuzenadah AM, Asif M, Alqahtani MH, Iqbal Z, Shaik MM, Gan SH, Kamal MA.
CNS Neurol Disord Drug Targets. 2014 Apr;13(3):533-42. doi: 10.2174/18715273113126660167.
A nanotechnological approach to the management of Alzheimer disease and type 2 diabetes
Alam Q, ZubairAlam M, Karim S, Gan SH, Kamal MA, Jiman-Fatani A, Damanhouri GA, Abuzenadah AM, Chaudhary AG, Haque A.
CNS Neurol Disord Drug Targets. 2014 Apr;13(3):478-86. doi: 10.2174/18715273113126660159.
Sohrab SS, Karim S, Kamal MA, Abuzenadah AM, Chaudhary AG, Al-Qahtani MH, Mirza Z.
CNS Neurol Disord Drug Targets. 2014 Apr;13(3):491-500. doi: 10.2174/18715273113126660158.
Diabetes of the brain: computational approaches and interventional strategies
Narasimhan K, Govindasamy M, Gauthaman K, Kamal MA, Abuzenadeh AM, Al-Qahtani M, Kanagasabai R.
CNS Neurol Disord Drug Targets. 2014 Apr;13(3):408-17. doi: 10.2174/18715273113126660156.
Mirza Z, Kamal MA, Buzenadah AM, Al-Qahtani MH, Karim S.
CNS Neurol Disord Drug Targets. 2014 Apr;13(3):501-16. doi: 10.2174/18715273113126660154.
How do periodontal infections affect the onset and progression of Alzheimer's disease?
Shaik MM, Ahmad S, Gan SH, Abuzenadah AM, Ahmad E, Tabrez S, Ahmed F, Kamal MA.
CNS Neurol Disord Drug Targets. 2014 Apr;13(3):460-6. doi: 10.2174/18715273113126660152.
Role of gut microbiota in obesity, type 2 diabetes and Alzheimer's disease
Naseer MI, Bibi F, Alqahtani MH, Chaudhary AG, Azhar EI, Kamal MA, Yasir M.
CNS Neurol Disord Drug Targets. 2014 Mar;13(2):305-11. doi: 10.2174/18715273113126660147.
Alzheimer's and type 2 diabetes treatment via common enzyme targeting
Jabir NR, Kamal MA, Abuzenadah AM, Gan SH, Alama MN, Baeesa SS, Tabrez S.
CNS Neurol Disord Drug Targets. 2014 Mar;13(2):299-304. doi: 10.2174/18715273113126660145.
Zemva J, Schubert M.
CNS Neurol Disord Drug Targets. 2014 Mar;13(2):322-37. doi: 10.2174/18715273113126660141.
Insulin-degrading enzyme: a link between Alzheimer's and type 2 diabetes mellitus
Haque R, Nazir A.
CNS Neurol Disord Drug Targets. 2014 Mar;13(2):259-64. doi: 10.2174/18715273113126660139.
Gauthaman K, Pushparaj PN, Rajeshkumar M, Narasimhan K, Al-Qahtani M, Cheung NS, Manikandan J.
CNS Neurol Disord Drug Targets. 2014 Mar;13(2):247-58. doi: 10.2174/18715273113126660138.
Molecular linkages between diabetes and Alzheimer's disease: current scenario and future prospects
Dar TA, Sheikh IA, Ganie SA, Ali R, Singh LR, Gan SH, Kamal MA, Zargar MA.
CNS Neurol Disord Drug Targets. 2014 Mar;13(2):290-8. doi: 10.2174/18715273113126660135.
Fighting Alzheimer's disease and type 2 diabetes: pathological links and treatment strategies
Dai Y, Kamal MA.
CNS Neurol Disord Drug Targets. 2014 Mar;13(2):271-82. doi: 10.2174/18715273113126660134.
Editorial: current update on association between Alzheimer's disease and type 2 diabetes: volume I
Kamal MA.
CNS Neurol Disord Drug Targets. 2014 Mar;13(2):192-6. doi: 10.2174/1871527313999140307101350.
Bonakis A, Economou NT, Paparrigopoulos T, Bonanni E, Maestri M, Carnicelli L, Di Coscio E, Ktonas P, Vagiakis E, Theodoropoulos P, Papageorgiou SG.
J Alzheimers Dis. 2014;38(1):85-91. doi: 10.3233/JAD-122014.
Actualización mensual Regístrese para recibir los avisos de actualización
Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.